In-vitro Bioequivalence (IVBE)
Off-the-shelf devices available for key identified nasal drugs
TECHNICAL FEATURES
- Off-the-shelf devices with IVBE requirements on priming/ re-priming, dose delivery and spray characteristics
- Several pump/ actuator combinations developed
- Various neck finishes: screw-on, snap-on and crimp-on
Please consult us for any question.
KEY ADVANTAGES
- “Fast-track” program meeting FDA IVBE requirements
- Based on track-record SP270+ platform and customized actuators
- In vitro Bioequivalence testing with state-of-the-art lab equipment, from screening tests to registration purposes
- Dedicated program & teams to answer a comprehensive clients’ support, including regulatory and statistics
Accelerate your time-to-market with IVBE Nemera devices!
Article “The very promising nasal route"
'The Pharmaceutical Post' magazine - Jan 2020
"Nasal sprays – Key insights for a successful device development to achieve bioequivalence requirements"
'BioScience Today' magazine - March 2018
Article “The development path to bioequivalence for a nasal spray"
'Pulmonary and Nasal Delivery' - November 2017
